{
  "metadata": {
    "document_id": "10_1016_j_chest_2017_01_024",
    "title": "Interventional Pulmonology Fellowship Accreditation Standards",
    "authors": [
      "John J. Mullon",
      "Kristin M. Burkart",
      "Gerard Silvestri",
      "D. Kyle Hogarth",
      "Francisco Almeida",
      "David Berkowitz",
      "George A. Eapen",
      "David Feller-Kopman",
      "Henry E. Fessler",
      "Erik Folch",
      "Colin Gillespie",
      "Andrew Haas",
      "Shaheen U. Islam",
      "Carla Lamb",
      "Stephanie M. Levine",
      "Adnan Majid",
      "Fabien Maldonado",
      "Ali I. Musani",
      "Craig Piquette",
      "Cynthia Ray",
      "Chakravarthy B. Reddy",
      "Otis Rickman",
      "Michael Simoff",
      "Momen M. Wahidi",
      "Hans Lee"
    ],
    "year": 2017,
    "journal": "Chest",
    "doi": "10.1016/j.chest.2017.01.024",
    "volume": "151",
    "issue": "5",
    "pages": "1114-1121",
    "citation": "Mullon, et al. (2017). Interventional Pulmonology Fellowship Accreditation Standards. Chest, 151(5), 1114-1121. https://doi.org/10.1016/j.chest.2017.01.024",
    "abstract": "Interventional pulmonology (IP) is a rapidly evolving subspecialty of pulmonary medicine. In the last 10 years, formal IP fellowships have increased substantially in number from five to now > 30. The vast majority of IP fellowship trainees are selected through the National Resident Matching Program, and validated in-service and certification examinations for IP exist. Practice standards and training guidelines for IP fellowship programs have been published; however, considerable variability in the environment, curriculum, and experience offered by the various fellowship programs remains, and there is currently no formal accreditation process in place to standardize IP fellowship training. Recognizing the need for more uniform training across the various fellowship programs, a multisociety accreditation committee was formed with the intent to establish common accreditation standards for all IP fellowship programs in the United States. This article provides a summary of those standards and can serve as an accreditation template for training programs and their offices of graduate medical education as they move through the accreditation process.",
    "abstract_source": "pubmed",
    "url": "https://linkinghub.elsevier.com/retrieve/pii/S0012369217300740",
    "pubmed_id": "28132754"
  },
  "source_file": "IP Fellowship Accreditation Standards.json",
  "sections": [
    {
      "title": "Interventional Pulmonology Fellowship Accreditation Standards",
      "content": "Executive Summary of the Multisociety Interventional Pulmonology Fellowship Accreditation Committee\nJohn J. Mullon, MD, FCCP; Kristin M. Burkart, MD, FCCP; Gerard Silvestri, MD, FCCP; D. Kyle Hogarth, MD, FCCP; Francisco Almeida, MD, FCCP; David Berkowitz, MD; George A. Eapen, MBBS, FCCP; David Feller-Kopman, MD, FCCP; Henry E. Fessler, MD, FCCP; Erik Folch, MD; Colin Gillespie, MD; Andrew Haas, MD, FCCP; Shaheen U. Islam, MBBS, MPH, FCCP; Carla Lamb, MD, FCCP; Stephanie M. Levine, MD, FCCP; Adnan Majid, MD, FCCP; Fabien Maldonado, MD, FCCP; Ali I. Musani, MD, FCCP; Craig Piquette, MD, FCCP; Cynthia Ray, MD, FCCP; Chakravarthy B. Reddy, MBBS, FCCP; Otis Rickman, DO, FCCP; Michael Simoff, MD, FCCP; Momen M. Wahidi, MD, FCCP; and Hans Lee, MD, FCCP\nInterventional pulmonology (IP) is a rapidly evolving subspecialty of pulmonary medicine. In the last 10 years, formal IP fellowships have increased substantially in number from /uniFB01 ve to now > 30. The vast majority of IP fellowship trainees are selected through the National Resident Matching Program, and validated in-service and certi /uniFB01 cation examinations for IP exist. Practice standards and training guidelines for IP fellowship programs have been published; however, considerable variability in the environment, curriculum, and experience offered by the various fellowship programs remains, and there is currently no formal accreditation process in place to standardize IP fellowship training. Recognizing the need for more uniform training across the various fellowship programs, a multisociety accreditation committee was formed with the intent to establish common accreditation standards for all IP fellowship programs in the United States. This article provides a summary of those standards and can serve as an accreditation template for training programs and their of /uniFB01 ces of graduate medical education as they move through the accreditation process. CHEST 2017; 151(5):1114-1121\nABBREVIATIONS: AABIP = American Association for Bronchology and Interventional Pulmonology; ABIM = American Board of Internal Medicine; ACGME = Accreditation Council for Graduate Medical Education; AIPPD = Association of Interventional Pulmonary Program Directors; APCCMPD = Association of Pulmonary and Critical Care Medicine Program Directors; ATS = American Thoracic Society; CHEST = American College of Chest Physicians; IP = interventional pulmonology; KCF = key clinical faculty\nAFFILIATIONS: From the Mayo Clinic (Dr Mullon), Rochester, MN; Columbia University Medical Center (Dr Burkart), New York, NY; Medical University of South Carolina (Dr Silvestri), Charleston, SC; University of Chicago Medical Center (Dr Hogarth), Chicago, IL; Cleveland Clinic Foundation (Dr Almeida), Cleveland, OH; Emory University (Dr Berkowitz), Atlanta, GA; University of Texas MD Anderson Cancer Center (Mr Eapen), Houston, TX; Johns Hopkins University (Drs Feller-Kopman, Fessler, and Lee), Baltimore, MD; Massachusetts General Hospital (Dr Folch), Harvard Medical School, Boston, MA; Northwestern University (Dr Gillespie), Evanston, IL; University of Pennsylvania (Dr Haas), Philadelphia, PA; The Ohio\nState University (Mr Islam), Columbus, OH; Lahey Hospital and Medical Center (Dr Lamb), Burlington, MA; University of Texas Health Science Center-San Antonio (Dr Levine), San Antonio, TX; Beth Israel Deaconess Medical Center (Dr Majid), Boston, MA; Vanderbilt University (Drs Maldonado and Rickman), Nashville, TN; Medical University of Wisconsin (Dr Musani), Milwaukee, WI; University of Nebraska (Dr Piquette), Omaha, NE; Henry Ford Hospital (Drs Simoff and Ray), Detroit, MI; University of Utah (Mr Reddy), Salt Lake City, UT; and Duke University (Dr Wahidi), Durham, NC.\nCORRESPONDENCE TO: John J. Mullon, MD, FCCP, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Gonda Building 18S, 200 First St SW, Rochester, MN 55905; e-mail: mullon.john@ mayo.edu\nCopyright /C211 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.\n[\n]\n[\n1 5 1 # 5\nCHEST\nMAY 2017\n]\nInterventional pulmonology (IP) is a rapidly evolving subspecialty of pulmonary medicine. IP focuses on the evaluation and management of thoracic diseases primarily involving the airways, lung parenchyma, and pleural space, while emphasizing minimally invasive diagnostic and therapeutic procedures. Although IP techniques such as rigid bronchoscopy and pleuroscopy have been practiced for more than a century, the last 20 years have seen a rapid and marked growth in available IP techniques and equipment. During this same time, professional organizations in both North America and Europe have recognized the unique skill set germane to IP and have taken steps to further de /uniFB01 ne its indications, desired outcomes, and training requirements. 1,2 Survey data indicate that pulmonary procedures and the management of complex pleural and airway diseases are not uniformly emphasized in contemporary pulmonary medicine training 3,4 ; however, other studies con /uniFB01 rm that the knowledge and skill to practice IP are measurably enhanced by additional, concentrated training and mentorship beyond that offered within a standard pulmonary medicine curriculum. 5\nAs a result, there has been rapid growth of dedicated 12-month IP fellowship training programs intended to solidify advanced pulmonary procedural knowledge and skill and to prepare trainees to become leaders in pulmonary procedural practice, education, and research. In 2007, /uniFB01 ve dedicated IP fellowship programs existed; in the last 8 years, that number has grown to > 30 such programs in the United States and Canada. To help facilitate quality training, the Association of Interventional Pulmonology Program Directors (AIPPD) was established in 2010, and now the majority of IP fellowship programs select their trainees through the National Resident Matching Program. 6 Validated IP in-service and board certi /uniFB01 cation examinations also now exist, with > 180 interventional pulmonologists across the United States and Canada certi /uniFB01 ed by the American Association for Bronchology and Interventional Pulmonology (AABIP). 5 A survey of\ngraduates found that 89% of IP fellowship graduates work directly in IP, with most (75%) holding academic appointments. 7\nDespite practice guidelines outlining the desired objectives, structure, and curriculum of IP fellowship programs, there is still considerable variability between IP training programs, 8,9 and to date, there has been no recognized fellowship accreditation process. To address this situation, the AABIP and the AIPPD established the Joint Interventional Pulmonology Fellowship Accreditation Committee with the mandate to construct a uniform accreditation standard for IP fellowship programs in the United States. This standard has now been reviewed and edited and was approved in June 2016 by the AABIP and AIPPD as well as by the American College of Chest Physicians (CHEST), the American Thoracic Society (ATS), and the Association of Pulmonary and Critical Care Medicine Program Directors (APCCMPD). It is published in full (e-Appendix 1, www.aabronchology. org, www.aippd.org), and the present article serves as an executive summary.\nIt is important to note that the accreditation standard as summarized here or in its full length is intended solely for the standardization of IP fellowship programs within the United States, with the intent to ensure that all IP fellowship training programs have the resources, expertise, facilities, curriculum, and caseload for adequate training. It is not intended to limit the current or future practice of pulmonologists who have not participated in IP fellowship training, nor is it intended to limit patient access to necessary procedures in the absence of a fellowship-trained interventional pulmonologist should those procedures be available through another competent provider. As such, the accreditation standard is intended to have no bearing on current or future reimbursement schedules for the procedures outlined, nor is it to be used in any way to limit reimbursement to physicians credentialed to perform those procedures even in the absence of formal IP fellowship training.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "Methods",
      "content": "In 2014, the AABIP and AIPPD created a committee with the mandate to establish accreditation standards for IP fellowship programs in the United States. The initial framework of the accreditation document was constructed by using existing Accreditation Council for\nGraduate Medical Education (ACGME) accreditation standards for medicine subspecialty fellowships, anesthesia, and thoracic surgery. This also included but was not limited to examining educational standards, faculty/institution requirements, fellowship appointment, and evaluations. Deliberation and voting were conducted by using Delphi methods. The draft accreditation standard was reviewed and\nrevised by the CHEST, ATS, and APCCMPD; input was also received from the CHEST Training and Transitions Committee and the Interventional Chest/Diagnostic Procedures NetWork Steering\nCommittee. The /uniFB01 nal multisociety accreditation standard was approved in June 2016 by the AABIP, CHEST, AIPPD, APCCMPD, and ATS.",
      "category": "methods",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "Results",
      "content": "The training and practice of IP build on the fundamental knowledge and procedural skill acquired during pulmonary and critical care medicine training, and encompass both cognitive and psychomotor domains. The /uniFB01 nal document outlines the minimum requirements for accreditation of a fellowship program and is intended to ensure that all accredited programs have adequate resources, facilities, expertise, curriculum, and procedural volumes with which to train a fellow in IP. The standard, as a whole or in part, is not intended to ascribe any speci /uniFB01 c level of competence to the individual IP fellowship graduate or other practitioners but rather to ensure the existence of an environment in which competence can be achieved. The determination of competence to practice independently as an interventional pulmonologist remains the responsibility of the IP fellowship program director and faculty, IP board certi /uniFB01 cation process, and institutional credentialing committees. The following is a summary of program attributes needed to satisfy accreditation requirements. The attributes outlined here represent the consensus of all /uniFB01 ve contributing societies. The actual accreditation process and adjudication to include the decision to grant full accreditation, accreditation with warning, or withhold accreditation entirely will be the responsibility of the AABIP and AIPPD via a Joint Accreditation Committee.",
      "category": "results",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "Duration of Training",
      "content": "All accredited IP fellowship programs must be no less than 12 months in duration. The 12-month curriculum must include ample instruction in the practice of IP, associated clinical specialties such as thoracic surgery and otolaryngology, and research. At a minimum, 9 months must be devoted to direct IP clinical training.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "Sponsoring Institution and Participating Sites",
      "content": "The sponsoring institution is the primary clinical site of the IP fellowship program and must also sponsor or be a participating site for an ACGME-accredited pulmonary or pulmonary and critical care medicine fellowship program. The sponsoring institution is responsible for providing the personnel and other resources necessary for the administrative functioning of the fellowship and is required to support no less than 10% of the\nprogram director ' s salary or equivalent protected time. The sponsoring institution assumes ultimate responsibility for the fellowship program, which includes responsibility for the resourcing, conduct, function, and curriculum of fellow assignments at all participating sites. As such, the sponsoring institution is responsible for adequate work and call facilities for fellows, electronic medical records, electronic medical literature databases and library facilities, and adequate clinical support services such as diagnostic radiology, critical care services, and pathology.\nParticipating sites are facilities separate from the sponsoring institution where fellows may receive portions of their clinical experience. All participating sites function within the con /uniFB01 nes of a program letter of agreement with the sponsoring institution that clearly outlines the educational and supervisory responsibilities as well as the content of the educational experience.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "Fellowship Program Director, Key Clinical Faculty, and Faculty",
      "content": "Each accredited IP fellowship is required to have a single fellowship program director appointed by the sponsoring institution ' s Graduate Medical Education Committee. Program directors must be board-certi /uniFB01 ed in IP and must have served as faculty within an ACGME-accredited pulmonary or pulmonary and critical care fellowship for at least 5 years before assuming the position of program director. The program director has overall responsibility for the curricular and administrative structure and function of the fellowship and must devote a minimum of 50% of his or her clinical, research, administrative, and/or educational effort to the practice of IP.\nIn addition to the program director, each IP fellowship program must have a minimum of one key clinical faculty (KCF) at the sponsoring institution for fellowships selecting up to two fellows per academic year. If more than two fellows are selected per academic year, additional KCFs are then required to satisfy at least one KCF per every 1.5 fellows. In addition, for programs with fellows rotating both at the sponsoring institution and at participating sites, a KCF is required for each participating site. KCFs are practicing IP\n[\n1 5 1 # 5\nCHEST\nMAY 2017\n]\nattending physicians who devote additional time and effort to the IP fellowship in the form of planning, implementation, monitoring, and evaluation of the fellows ' clinical and research education. They are required to be board-certi /uniFB01 ed in IP and devote a minimum of 33% of their clinical, administrative, research, and/or educational time to IP. In addition, KCFs are expected to act as and on behalf of the program director in the event of an unexpected prolonged absence of the program director.\nIn addition to the program director and KCFs, every IP fellowship is required to have a suf /uniFB01 cient number of faculty to instruct and supervise all fellows in IP as well as in associated specialties. These physicians are required to maintain board certi /uniFB01 cation within their primary subspecialty and are not required to obtain board certi /uniFB01 cation in IP. As faculty, these physicians have regular contact with the IP fellows and are actively engaged in the instruction, supervision, and evaluation of trainees.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "Fellow Appointments",
      "content": "Each selected fellow must /uniFB01 rst successfully complete an ACGME-accredited pulmonary or pulmonary/critical care fellowship program, or a Royal College of Physicians and Surgeons of Canada-accredited pulmonary or pulmonary/critical care fellowship program. The program ' s educational resources must be suf /uniFB01 cient to support adequate patient and procedural exposure for each of the fellows appointed to the program.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "Educational Program",
      "content": "IP involves the care of patients with both nonmalignant and malignant airway, pleural, mediastinal, and parenchymal lung diseases. Accredited training programs in IP must provide a broad exposure to patients experiencing both malignant and nonmalignant diseases of the thorax. Fellows must participate in weekly clinical case conferences, journal clubs, research conferences, and morbidity and mortality or quality improvement conferences. Fellows must also attend an outpatient clinic to provide preprocedural evaluation and follow-up care for patients. A minimum of 44 half-day clinics must be completed during a 12-month fellowship. Each program must also provide an opportunity for fellows to participate in research or other scholarly activities. The program director and fellowship program must administer and maintain an educational environment conducive\nto educating the fellows in each of the ACGME competency areas as they pertain to the practice of IP. ACGME competency areas include medical knowledge, patient care, communication and interpersonal skills, professionalism, practice-based learning and improvement, and systems-based practice.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "Medical Knowledge",
      "content": "Fellows must demonstrate in-depth knowledge of IP-related disease processes as well as established and evolving biomedical, clinical, epidemiologic, and socialbehavioral sciences and demonstrate the ability to apply this knowledge to patient care. A didactic lecture series is required with a minimum of once monthly lectures delivered by faculty. Although not exhaustive, Table 1 illustrates the current disease and practice-speci /uniFB01 c topics required within the fellowship core curriculum. This list re /uniFB02 ects the knowledge base currently expected of a practicing interventional pulmonologist and represents the core topics tested on the IP board certi /uniFB01 cation examination. The topics listed are subject to change as the practice of IP evolves.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "Patient Care",
      "content": "Fundamentally, IP is a procedural specialty, and fellows must be able to competently perform all medical, diagnostic, and surgical procedures considered essential for the practice of IP. The program director is responsible for determining fellow procedural competence based on a combination of case presentations and procedural planning, direct procedural observation, faculty evaluations, outcomes and complications tracking, and procedural exposure accumulated during previous training. When available, validated assessment tools should be further utilized and documented in assessing procedural competence. Procedural simulation using cadaveric, animal, and/or manufactured simulation models is required. To maintain staff and faculty expertise and adequate fellow exposure to relevant patient factors and complications, minimum institutional procedural volumes (not individual fellow procedural volumes) are required to accredit IP fellowship programs (Table 2). Although all procedures listed are considered core IP procedures, competence in some of these procedures may be acquired during a prior pulmonary or pulmonary and critical care medicine fellowship.\nSpeci /uniFB01 c required procedural numbers were selected based on published expert opinion and IP fellowship",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "TABLE 1 ] Disease- and Practice-Speci /uniFB01 c Core Curriculum Topics",
      "content": "(Continued)\n[\n1 5 1 # 5\nCHEST\nMAY 2017\n]\nprogram self-reporting in an effort to structure a fellowship experience that is robust and meets the needs of trainees while simultaneously setting a standard that is achievable. 1,2,9 There is no expectation that individual fellows need to meet or exceed those institutional\nprocedural volumes for any single procedure, nor do those volumes represent metrics for an individual ' s competency for any given procedure. Where designated, procedures must be performed by or under the direction of designated fellowship faculty.\nThese requirements assume basic disease-speci /uniFB01 c knowledge of general pulmonary and critical care training as a baseline. Required items are subject to change as the practice of interventional pulmonology (IP) evolves. KTP Â¼ potassium titanyl phosphate.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "Program Administration",
      "content": "Every program is required to establish a Clinical Competency Committee and Program Evaluation Committee whose responsibilities include assessing fellow competency and monitoring program, faculty,\nand curriculum quality. All accredited programs must adhere to published ACGME duty hour requirements.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "Discussion",
      "content": "The medical profession in the United States has the responsibility for self-regulation. Two primary mechanisms are used to ensure patient safety, as well as quality and uniformity of care. First, accreditation standards de /uniFB01 ne the training, skills, knowledge, and competencies speci /uniFB01 c to a medical specialty or subspecialty. Second, certi /uniFB01 cation boards administer independent assessments of individual practitioner knowledge and skill within that specialty or subspecialty. Since 2014, the AABIP has conducted an IP board certi /uniFB01 cation examination with a dual track eligibility process that permits both IP fellowship graduates and practicing interventional pulmonologists to qualify for the examination. Beginning in 2017, only IP fellowship graduates will be eligible for board certi /uniFB01 cation, with an estimated 30 to 40 new matriculates per year depending on the number of accredited fellowships.\nEven as the number of IP fellowships grows each year, a uniform accreditation standard outlining the required curriculum and fellowship environment has not existed. This document summarizes just such a standard with the full accreditation standard available online at the AABIP and AIPPD websites and in e-Appendix 1 and e-Table. The standard has been constructed by using existing literature and guidelines and through a formal process with representation from the major professional organizations representing IP and pulmonary medicine in the United States. The intent of this multiyear and multisociety endeavor is to more speci /uniFB01 cally de /uniFB01 ne the training of IP practitioners in the United States and thereby better assure quality of care and standardization of the IP skill set. A formal accreditation process will further safeguard the expectations of fellowship applicants, patients, and potential employers.\nIt should be clearly stated that the goal of this accreditation standard was not to exclude fellowship programs but to raise the quality of all programs to a common level of excellence, and it is the stated intent of the AABIP and AIPPD to make every effort to assist programs in their pursuit of accreditation. Furthermore, because IP is an evolving subspecialty of pulmonary medicine, there remain many pulmonary practitioners who perform various procedures and techniques outlined in this standard as core IP procedures. The intent is in no way to limit the practice of or access to\na If graduates are to be certi /uniFB01 ed as competent in these procedures during interventional pulmonology (IP) training, the minimum institutional volumes must be available to assure suf /uniFB01 cient opportunity for hands-on training.\n[\n1 5 1 # 5\nCHEST\nMAY 2017\n]\nthese practitioners, rede /uniFB01 ne or limit the future training of pulmonary or pulmonary and critical care fellows, nor to have any bearing on current or future reimbursement for the procedures outlined herein.",
      "category": "discussion",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "Future Steps",
      "content": "This accreditation standard is the product of a joint multisociety effort. The document and standard itself will, by design, evolve as the practice of IP evolves. Any additions, deletions, or edits to the current accreditation standard will likewise be the action of a joint multisociety effort. The actual process of accreditation, however, will remain the responsibility of the AABIP and AIPPD via the assessments and recommendations of a Joint Fellowship Accreditation Committee.\nThere are still challenges facing this /uniFB01 eld, which is in its infancy. Within academic circles, it is unclear how practitioners of IP hired with the expectation of carrying a heavy clinical load can advance in the traditional academic setting. Furthermore, because IP training programs are structured largely based on providing fellows with a clinical exposure and limited dedicated research time, it is unclear how they will develop the research skills to elevate the profession and prepare a portion of those interested in pursuing an academic career. Some programs have already recognized this concern and have instituted a second year of fellowship training to incorporate a more robust research exposure into the IP fellowship.\nPriority must be given to research regarding competency to perform the procedures germane to this /uniFB01 eld. Traditional metrics such as individual procedural volume have largely been opinion-based and do not account for the intangibles such as an understanding of the indications, contraindications, risks and bene /uniFB01 ts to the patient, and alternative treatment options. In addition, there is variation in learners ' psychomotor coordination such that reaching a target volume for some will not ensure competency while others may master that same procedure much more ef /uniFB01 ciently. Finally, how new procedures will be introduced into the /uniFB01 eld has largely been a haphazard exercise. New technologies may be costly, can incur patient risk, and at times do not contribute meaningfully to patient care. IP practitioners must take a leadership role in the evaluation of new technologies and the incorporation of new technology, when appropriate, into the pulmonary practitioner ' s armamentarium.\nHowever, standardizing fellowship training requirements so that there is uniform training in IP is an important /uniFB01 rst step in the continuing evolution of this specialty within a specialty. This document should be considered a starting point that will evolve over time and result in better training for practitioners and better care for the patients.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "Acknowledgments",
      "content": "Author contributions: All authors contributed equally to the work.\nFinancial/non /uniFB01 nancial disclosures: The authors have reported to CHEST the following: D. K. H. has served as a consultant/lectured for Auris, Boston Scienti /uniFB01 c, Body Vision, Medtronic, and Spiration and received unrestricted educational grants from Boston Scienti /uniFB01 c and Medtronic. E. F. has served as a scienti /uniFB01 c consultant for Boston Scienti /uniFB01 c, an educational consultant for Olympus, and principal investigator for clinical trial funded by Medtronic. C. G. has served on scienti /uniFB01 c advisory boards for Medtronic, Olympus, and Boston Scienti /uniFB01 c and consulted for Auris Robotics and Boston Scienti /uniFB01 c. C. L. has served as an educational consultant for Boston Scienti /uniFB01 c. A. I. M. is President-Elect of the American Association for Bronchology and Interventional Pulmonology. O. R. has received grant money from Medtronic, Olympus, and Chiltern; he has served as a consultant/ advisory board member to Medtronic, Olympus, Spiration, and Boston Scienti /uniFB01 c; and he is a faculty member for simulation-based courses sponsored by CHEST and is also a nonvoting member of the CHEST Bronchoscopy Domain Task Force Committee. O. R. is also a member of the board of directors of the AABIP, a co-sponsor of this executive summary. H. L. has served as a consultant to Veran Medical and Fuji Medical. None declared (J. J. M., K. M. B., G. S., F. A., D. B., G. A. E., D. F.-K., H. E. F., A. H., S. U. I., S. M. L., A. M., F. M., C. P., C. R., C. B. R., M. S., M. M. W.).\nAdditional information: The e-Appendix and e-Table can be found in the Supplemental Materials section of the online article.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    },
    {
      "title": "References",
      "content": "1. Bollinger CT, Mathur PN, Beamis JF, et al; European Respiratory Society/American Thoracic Society. ERS/ATS statement on interventional pulmonology. Eur Respir J . 2002;19(2):356-373.\n2. Ernst A, Silvestri G, Johnstone D; American College of Chest Physicians. Interventional pulmonary procedures: guidelines from the American College of Chest Physicians. Chest . 2003;123(5): 1693-1717.\n3. Pastis NJ, Nietert PJ, Silvestri GA. American College of Chest Physicians Interventional Chest/Diagnostic Procedures Network Steering Committee, Variation in training for interventional pulmonary procedures among US pulmonary/critical care fellowships: a survey of fellowship directors. Chest . 2005;127(5):1614-1621.\n4. Stather DR, Jarand J, Silvestri GA, et al. An evaluation of procedural training in Canadian respirology fellowship programs: program directors ' and fellows ' perspectives. Can Respir J . 2009; 16(2):55-59.\n5. Lee HL, Feller-Kopman D, Shepherd W, et al. Validation of an interventional pulmonary examination. Chest . 2013;143(6):1667-1670.\n6. Feller-Kopman D, Mehta A. Special announcement: interventional pulmonary match. J Bronchology Interv Pulmonol . 2011;18(4):337.\n7. Lee HL, Feller-Kopman D, Islam S, et al. Analysis of employment data for interventional pulmonary fellowship graduates. Ann Am Thorac Soc . 2015;12(4):549-552.\n8. Lamb CR, Feller-Kopman D, Ernst A, et al. An approach to interventional pulmonary fellowship training. Chest . 2010;137(1): 195-199.\n9. Yarmus L, Feller-Kopman D, Imad M, et al. Procedural volume and structure of interventional pulmonary fellowships: a survey of fellows and fellowship program directors. Chest . 2013;144(3):935-939.",
      "category": "other",
      "level": null,
      "page_start": null,
      "page_end": null,
      "section_id": null
    }
  ],
  "tables": [
    {
      "id": "table",
      "caption": "",
      "headers": null,
      "rows": [
        [
          "Scienti /uniFB01 c method and evidence-based decision-making, to include:"
        ],
        [
          "Study design"
        ],
        [
          "Research ethics"
        ],
        [
          "Medical biostatistics"
        ],
        [
          "Anatomic, physiologic, and physical properties as they pertain to IP, to include:"
        ],
        [
          "Tracheal, bronchial, vascular, lymphatic, pulmonary, and cardiac anatomy, physiology, and pathophysiology"
        ],
        [
          "Pathophysiology of central airway obstruction"
        ],
        [
          "Wound healing and host factor responses to injury"
        ],
        [
          "Properties of endobronchial thermal and ablative treatment technologies, to include:"
        ],
        [
          "I. Laser therapy (eg, Nd:YAG, KTP, CO 2 , YAP)"
        ],
        [
          "II. Electrocautery"
        ],
        [
          "III. Argon plasma coagulation"
        ],
        [
          "IV. Cryotherapy"
        ],
        [
          "V. Photodynamic therapy"
        ],
        [
          "Principles and physical properties of airway stents"
        ],
        [
          "Principles of advanced airway, mediastinal, and lung parenchymal imaging enhancement techniques, to include:"
        ],
        [
          "I. Auto /uniFB02 uorescence"
        ],
        [
          "II. Narrow band imaging"
        ],
        [
          "IV. Optical coherence tomography"
        ],
        [
          "V. Endoscopic radial and convex ultrasound"
        ],
        [
          "VI. Transthoracic ultrasound"
        ],
        [
          "VII. CT scan"
        ],
        [
          "VIII. MRI scan"
        ],
        [
          "IX. PET scan"
        ],
        [
          "I. Lung cancer"
        ],
        [
          "II. Malignant"
        ],
        [
          "mesothelioma"
        ],
        [
          "Basic principles of chemotherapy as they apply to thoracic"
        ],
        [
          "malignancies"
        ],
        [
          "Administering, monitoring, and managing moderate sedation"
        ],
        [
          "Prevention, evaluation, and management of patients with speci /uniFB01 c disease entities pertinent to the practice of IP, including:"
        ],
        [
          "III. Mixed intrinsic and extrinsic obstructing tumor"
        ],
        [
          "Nonmalignant airway obstruction secondary to, but not"
        ],
        [
          "limited to:"
        ],
        [
          "I. Foreign body"
        ],
        [
          "III. Granulomatosis with polyangiitis"
        ],
        [
          "IV. Postintubation/tracheostomy"
        ],
        [
          "V. TB"
        ]
      ],
      "footnotes": [],
      "page": null
    },
    {
      "id": "table",
      "caption": "",
      "headers": null,
      "rows": [
        [
          "VII. Amyloidosis"
        ],
        [
          "VIII. Respiratory papillomatosis"
        ],
        [
          "IX. Broncholithiasis"
        ],
        [
          "X. Tracheal/bronchial malacia/excessive dynamic airway collapse (relapsing polychondritis, Mounier-Kuhn syndrome)"
        ],
        [
          "XI. Airway complications following airway surgery/lung transplant to include anastomotic strictures/granulation"
        ],
        [
          "XII. Airway stent-associated granulation tissue"
        ],
        [
          "XIII. Extrinsic compression from, for example, goiter, mediastinal cyst, lymphadenopathy"
        ],
        [
          "Loss of airway integrity secondary to, but not limited to:"
        ],
        [
          "I. Anastomotic dehiscence"
        ],
        [
          "II. Tracheo/bronchial-esophageal /uniFB01 stula"
        ],
        [
          "III. Bronchopleural/alveolar-pleural /uniFB01 stula"
        ],
        [
          "Premalignant and early-stage malignant airway disease"
        ],
        [
          "The guidelines, principles, and practice of thoracic malignancy screening"
        ],
        [
          "Undiagnosed mediastinal and hilar lymphadenopathy"
        ],
        [
          "Massive hemoptysis"
        ],
        [
          "Solitary pulmonary nodules"
        ],
        [
          "Evaluation, diagnosis, and management of pleural disease, to include:"
        ],
        [
          "I. Malignant pleural effusion"
        ],
        [
          "II. Recurrent nonmalignant pleural effusion and pleuritis"
        ],
        [
          "III. Pneumothorax"
        ],
        [
          "IV. Pleural space infection"
        ],
        [
          "V. The undiagnosed pleural effusion"
        ],
        [
          "VI. Chylothorax"
        ],
        [
          "VII. Hepatic hydrothorax/effusions due to refractory congestive heart failure"
        ],
        [
          "Prevention and management of mechanical complications of interventional pulmonary procedures, which may include"
        ],
        [
          "Simple and tension pneumothorax, hemothorax"
        ],
        [
          "Airway disruption, perforation, tear"
        ],
        [
          "Massive hemoptysis"
        ],
        [
          "Refractory hypoxia/respiratory failure"
        ],
        [
          "Injury to adjacent organs (eg, esophageal perforation during percutaneous dilational tracheostomy placement)"
        ],
        [
          "Secondary tracheal stenosis"
        ],
        [
          "(posttracheostomy)"
        ],
        [
          "Safety, administrative, and business aspects pertinent to the practice of IP, to include"
        ],
        [
          "Secondary bronchial/tracheal strictures from laser/electrocautery/mechanical trauma/anastomotic complications"
        ],
        [
          "Procedural quality control management"
        ],
        [
          "Equipment maintenance and procedural suite design"
        ],
        [
          "Infection control policies and procedures"
        ],
        [
          "Radiation physics, biology, and safety"
        ],
        [
          "related to the use of radiograph imaging equipment"
        ],
        [
          "Laser physics and safety"
        ]
      ],
      "footnotes": [],
      "page": null
    },
    {
      "id": "table",
      "caption": "{'cref': '#/texts/77'}",
      "headers": [
        "Procedure Type",
        "Requisite Annual Institutional Case Volume"
      ],
      "rows": [
        [
          "Demonstration of competence is mandatory for IP fellows",
          ""
        ],
        [
          "Rigid bronchoscopy",
          "50"
        ],
        [
          "Endobronchial stenting",
          "20"
        ],
        [
          "Thoracoscopy",
          "20"
        ],
        [
          "Bronchoscopic navigation",
          "20"
        ],
        [
          "Endobronchial ablation",
          "50"
        ],
        [
          "Endobronchial ultrasound",
          "100"
        ],
        [
          "Image-guided thoracostomy tube placement",
          "20"
        ],
        [
          "Tunneled pleural catheter placement",
          "20"
        ],
        [
          "Training to competence may be offered during IP fellowship a",
          ""
        ],
        [
          "Percutaneous dilational tracheostomy",
          "20"
        ],
        [
          "Percutaneous endoscopic gastrostomy",
          "20"
        ],
        [
          "Bronchial thermoplasty",
          "6"
        ],
        [
          "Endobronchial management of bronchopleural /uniFB01 stula",
          "5"
        ],
        [
          "Endoscopic ultrasound",
          "30"
        ],
        [
          "Transtracheal oxygen catheter",
          "5"
        ],
        [
          "Image-guided percutaneous needle biopsy",
          "5"
        ]
      ],
      "footnotes": [],
      "page": null
    }
  ],
  "figures": [
    {
      "id": "picture",
      "caption": "",
      "page": null
    },
    {
      "id": "picture",
      "caption": "",
      "page": null
    }
  ],
  "references": [
    {
      "title": "ERS/ATS statement on interventional pulmonology"
    },
    {
      "title": "Eur Respir J",
      "year": 2002
    },
    {
      "title": "Interventional pulmonary procedures: guidelines from the American College of Chest Physicians",
      "year": 2002
    },
    {
      "title": "Chest",
      "year": 2002
    },
    {
      "title": "American College of Chest Physicians Interventional Chest/Diagnostic Procedures Network Steering Committee, Variation in training for interventional pulmonary procedures among US pulmonary/critical care fellowships: a survey of fellowship directors",
      "year": 2003
    },
    {
      "title": "An evaluation of procedural training in Canadian respirology fellowship programs: program directors&apos; and fellows&apos; perspectives",
      "year": 2005
    },
    {
      "title": "Can Respir J",
      "year": 2009
    },
    {
      "title": "Validation of an interventional pulmonary examination",
      "year": 2009
    },
    {
      "title": "Special announcement: interventional pulmonary match",
      "year": 2013
    },
    {
      "title": "J Bronchology Interv Pulmonol",
      "year": 2013
    },
    {
      "title": "Analysis of employment data for interventional pulmonary fellowship graduates",
      "year": 2011
    },
    {
      "title": "Ann Am Thorac Soc",
      "year": 2015
    },
    {
      "title": "An approach to interventional pulmonary fellowship training",
      "year": 2015
    },
    {
      "title": "Procedural volume and structure of interventional pulmonary fellowships: a survey of fellows and fellowship program directors",
      "year": 2010
    }
  ],
  "quality": {
    "completeness_score": 0,
    "has_abstract": true,
    "abstract_source": "pubmed",
    "has_doi": true,
    "has_full_text": true,
    "num_sections": 16,
    "num_tables": 3,
    "num_figures": 2,
    "num_references": 14
  }
}